ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,302Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 617

$663K Total Retail Price of All Prescriptions

Rank: 32 out of 617

518 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 15,894 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 690 687 1 4
SIMVASTATIN 647 645 2 2
WARFARIN SODIUM 549 548 3 7
OMEPRAZOLE 546 536 4 3
LEVOTHYROXINE SODIUM 546 544 4 1
ATORVASTATIN CALCIUM 408 408 6 14
AMLODIPINE BESYLATE 393 379 7 6
LOSARTAN POTASSIUM 359 355 8 22
POTASSIUM CHLORIDE 345 338 9 10
LISINOPRIL 343 341 10 5
METOPROLOL TARTRATE 334 333 11 11
CARVEDILOL 295 290 12 19
TRAMADOL HCL 245 243 13 15
MIRTAZAPINE 234 234 14 50
POLYETHYLENE GLYCOL 3350 221 221 15 32
GABAPENTIN 221 219 15 16
SERTRALINE HCL 212 206 17 20
METFORMIN HCL 210 194 18 9
NAMENDA 198 198 19 35
HYDROCODONE-ACETAMINOPHEN 194 188 S3 20 8
DONEPEZIL HCL 186 186 21 30
ALENDRONATE SODIUM 180 180 22 25
METOPROLOL SUCCINATE 178 166 23 12
CITALOPRAM HBR 171 171 24 18
TAMSULOSIN HCL 170 155 25 26
ALLOPURINOL 164 164 26 27
SPIRONOLACTONE 155 150 27 42
ENALAPRIL MALEATE 143 143 28 34
PREDNISONE 138 135 29 31
ISOSORBIDE MONONITRATE ER 138 138 29 52
DILTIAZEM 24HR ER 134 134 31 162
CHLORTHALIDONE 132 124 32 123
GLIMEPIRIDE 130 123 33 33
PRAVASTATIN SODIUM 126 126 34 21
HYDROCHLOROTHIAZIDE 123 111 35 13
ZOLPIDEM TARTRATE 110 109 36 23
CIPROFLOXACIN HCL 102 97 37 60
FINASTERIDE 99 99 38 104
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 39 46
NAPROXEN 96 96 40 101
ATENOLOL 93 93 41 17
DOXAZOSIN MESYLATE 88 88 42 79
DIOVAN 86 86 43 41
PANTOPRAZOLE SODIUM 86 83 43 37
CLOPIDOGREL 85 85 45 53
QUETIAPINE FUMARATE 84 79 46 78
TRIAMTERENE-HCTZ 83 82 47 47
TORSEMIDE 82 82 48 110
TRIAMCINOLONE ACETONIDE 82 79 48 102
RANITIDINE HCL 80 80 50 40
BUSPIRONE HCL 77 77 51 131
DIGOXIN 76 76 52 48
SPIRIVA 73 49 53 61
FLUTICASONE PROPIONATE 71 71 54 36
METOCLOPRAMIDE HCL 71 71 54 125
FENTANYL 68 68 S2 56 45
AZITHROMYCIN 67 65 57 70
LEVOFLOXACIN 67 63 57 89
CEPHALEXIN 66 64 59 68
LANTUS 66 49 59 39
ACTOS 64 64 61 85
CYMBALTA 61 61 62 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 58 63 29
PROPRANOLOL HCL 59 59 64 109
GLYBURIDE 57 57 R 65 84
ROPINIROLE HCL 57 57 65 66
ATENOLOL-CHLORTHALIDONE 54 54 67 142
PAROXETINE HCL 54 53 67 62
CLOTRIMAZOLE-BETAMETHASONE 52 52 69 175
HYDRALAZINE HCL 52 52 69 164
LACTULOSE 51 51 71 179
PLAVIX 51 51 71 86
RAMIPRIL 51 39 71 67
PHENYTOIN SODIUM EXTENDED 50 50 74 121
BENAZEPRIL HCL 50 50 74 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.